Publication Information

{'id': 'https://openalex.org/W1974761077', 'doi': 'https://doi.org/10.1097/00006676-200211000-00011', 'title': 'Adenosine Uptake Inhibition Ameliorates Cerulein-Induced Acute Pancreatitis in Mice', 'display_name': 'Adenosine Uptake Inhibition Ameliorates Cerulein-Induced Acute Pancreatitis in Mice', 'publication_year': 2002, 'publication_date': '2002-11-01', 'ids': {'openalex': 'https://openalex.org/W1974761077', 'doi': 'https://doi.org/10.1097/00006676-200211000-00011', 'mag': '1974761077', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/12409834'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00006676-200211000-00011', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S10058814', 'display_name': 'Pancreas', 'issn_l': '0885-3177', 'issn': ['0885-3177', '1536-4828'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5085546352', 'display_name': 'Tohru Noji', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I205823427', 'display_name': 'Kyowa Kirin (Japan)', 'ror': 'https://ror.org/000wej815', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I205823427']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Tohru Noji', 'raw_affiliation_strings': ['Manuscript received September 18, 2001', 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'revised manuscript accepted March 6, 2002.'], 'affiliations': [{'raw_affiliation_string': 'Manuscript received September 18, 2001', 'institution_ids': []}, {'raw_affiliation_string': 'revised manuscript accepted March 6, 2002.', 'institution_ids': []}, {'raw_affiliation_string': 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'institution_ids': ['https://openalex.org/I205823427']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062271490', 'display_name': 'Ken‐ichiro Nan‐ya', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I205823427', 'display_name': 'Kyowa Kirin (Japan)', 'ror': 'https://ror.org/000wej815', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I205823427']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Ken-ichiro Nan-ya', 'raw_affiliation_strings': ['Manuscript received September 18, 2001', 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'revised manuscript accepted March 6, 2002.'], 'affiliations': [{'raw_affiliation_string': 'revised manuscript accepted March 6, 2002.', 'institution_ids': []}, {'raw_affiliation_string': 'Manuscript received September 18, 2001', 'institution_ids': []}, {'raw_affiliation_string': 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'institution_ids': ['https://openalex.org/I205823427']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017243181', 'display_name': 'Chikako Katagiri', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I205823427', 'display_name': 'Kyowa Kirin (Japan)', 'ror': 'https://ror.org/000wej815', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I205823427']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Chikako Katagiri', 'raw_affiliation_strings': ['Manuscript received September 18, 2001', 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'revised manuscript accepted March 6, 2002.'], 'affiliations': [{'raw_affiliation_string': 'revised manuscript accepted March 6, 2002.', 'institution_ids': []}, {'raw_affiliation_string': 'Manuscript received September 18, 2001', 'institution_ids': []}, {'raw_affiliation_string': 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'institution_ids': ['https://openalex.org/I205823427']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036772212', 'display_name': 'Mirai Mizutani', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I205823427', 'display_name': 'Kyowa Kirin (Japan)', 'ror': 'https://ror.org/000wej815', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I205823427']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Mirai Mizutani', 'raw_affiliation_strings': ['Manuscript received September 18, 2001', 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'revised manuscript accepted March 6, 2002.'], 'affiliations': [{'raw_affiliation_string': 'revised manuscript accepted March 6, 2002.', 'institution_ids': []}, {'raw_affiliation_string': 'Manuscript received September 18, 2001', 'institution_ids': []}, {'raw_affiliation_string': 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'institution_ids': ['https://openalex.org/I205823427']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111782840', 'display_name': 'Junichi Sano', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I205823427', 'display_name': 'Kyowa Kirin (Japan)', 'ror': 'https://ror.org/000wej815', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I205823427']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Jun-ichi Sano', 'raw_affiliation_strings': ['Manuscript received September 18, 2001', 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'revised manuscript accepted March 6, 2002.'], 'affiliations': [{'raw_affiliation_string': 'revised manuscript accepted March 6, 2002.', 'institution_ids': []}, {'raw_affiliation_string': 'Manuscript received September 18, 2001', 'institution_ids': []}, {'raw_affiliation_string': 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'institution_ids': ['https://openalex.org/I205823427']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058960117', 'display_name': 'Satoshi Nishikawa', 'orcid': 'https://orcid.org/0000-0003-0905-8615'}, 'institutions': [{'id': 'https://openalex.org/I205823427', 'display_name': 'Kyowa Kirin (Japan)', 'ror': 'https://ror.org/000wej815', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I205823427']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Satoshi Nishikawa', 'raw_affiliation_strings': ['Manuscript received September 18, 2001', 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'revised manuscript accepted March 6, 2002.'], 'affiliations': [{'raw_affiliation_string': 'revised manuscript accepted March 6, 2002.', 'institution_ids': []}, {'raw_affiliation_string': 'Manuscript received September 18, 2001', 'institution_ids': []}, {'raw_affiliation_string': 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'institution_ids': ['https://openalex.org/I205823427']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034024012', 'display_name': 'Akira Karasawa', 'orcid': 'https://orcid.org/0000-0003-4977-1474'}, 'institutions': [{'id': 'https://openalex.org/I205823427', 'display_name': 'Kyowa Kirin (Japan)', 'ror': 'https://ror.org/000wej815', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I205823427']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Akira Karasawa', 'raw_affiliation_strings': ['Manuscript received September 18, 2001', 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'revised manuscript accepted March 6, 2002.'], 'affiliations': [{'raw_affiliation_string': 'revised manuscript accepted March 6, 2002.', 'institution_ids': []}, {'raw_affiliation_string': 'Manuscript received September 18, 2001', 'institution_ids': []}, {'raw_affiliation_string': 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'institution_ids': ['https://openalex.org/I205823427']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5057944066', 'display_name': 'Hideaki Kusaka', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I205823427', 'display_name': 'Kyowa Kirin (Japan)', 'ror': 'https://ror.org/000wej815', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I205823427']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hideaki Kusaka', 'raw_affiliation_strings': ['Manuscript received September 18, 2001', 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'revised manuscript accepted March 6, 2002.'], 'affiliations': [{'raw_affiliation_string': 'revised manuscript accepted March 6, 2002.', 'institution_ids': []}, {'raw_affiliation_string': 'Manuscript received September 18, 2001', 'institution_ids': []}, {'raw_affiliation_string': 'Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan', 'institution_ids': ['https://openalex.org/I205823427']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5085546352'], 'corresponding_institution_ids': ['https://openalex.org/I205823427'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.875, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 9, 'citation_normalized_percentile': {'value': 0.722471, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 79, 'max': 80}, 'biblio': {'volume': '25', 'issue': '4', 'first_page': '387', 'last_page': '392'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10760', 'display_name': 'Pancreatitis Pathology and Treatment', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10760', 'display_name': 'Pancreatitis Pathology and Treatment', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11193', 'display_name': 'Adenosine and Purinergic Signaling', 'score': 0.9936, 'subfield': {'id': 'https://openalex.org/subfields/1314', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10881', 'display_name': 'Blood Coagulation and Thrombosis Mechanisms', 'score': 0.9648, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/ceruletide', 'display_name': 'Ceruletide', 'score': 0.41858295}], 'concepts': [{'id': 'https://openalex.org/C2776670229', 'wikidata': 'https://www.wikidata.org/wiki/Q854573', 'display_name': 'Acute pancreatitis', 'level': 2, 'score': 0.78113174}, {'id': 'https://openalex.org/C2776991684', 'wikidata': 'https://www.wikidata.org/wiki/Q190012', 'display_name': 'Adenosine', 'level': 2, 'score': 0.76931155}, {'id': 'https://openalex.org/C2775967933', 'wikidata': 'https://www.wikidata.org/wiki/Q1527888', 'display_name': 'Pancreatitis', 'level': 2, 'score': 0.61737204}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.59803665}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5771037}, {'id': 'https://openalex.org/C67907053', 'wikidata': 'https://www.wikidata.org/wiki/Q356147', 'display_name': 'Adenosine receptor', 'level': 4, 'score': 0.55399406}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.5203073}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.43840688}, {'id': 'https://openalex.org/C2776731452', 'wikidata': 'https://www.wikidata.org/wiki/Q5065299', 'display_name': 'Ceruletide', 'level': 4, 'score': 0.41858295}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.19990224}, {'id': 'https://openalex.org/C2777593968', 'wikidata': 'https://www.wikidata.org/wiki/Q60315441', 'display_name': 'Cholecystokinin', 'level': 3, 'score': 0.068886966}, {'id': 'https://openalex.org/C2778938600', 'wikidata': 'https://www.wikidata.org/wiki/Q389934', 'display_name': 'Agonist', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D010195', 'descriptor_name': 'Pancreatitis', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011799', 'descriptor_name': 'Quinazolines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D013806', 'descriptor_name': 'Theophylline', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D000208', 'descriptor_name': 'Acute Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D000681', 'descriptor_name': 'Amylases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000681', 'descriptor_name': 'Amylases', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001692', 'descriptor_name': 'Biological Transport', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001692', 'descriptor_name': 'Biological Transport', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D002108', 'descriptor_name': 'Ceruletide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004176', 'descriptor_name': 'Dipyridamole', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004176', 'descriptor_name': 'Dipyridamole', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008049', 'descriptor_name': 'Lipase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008049', 'descriptor_name': 'Lipase', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008807', 'descriptor_name': 'Mice, Inbred BALB C', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008956', 'descriptor_name': 'Models, Chemical', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010195', 'descriptor_name': 'Pancreatitis', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': False}, {'descriptor_ui': 'D010195', 'descriptor_name': 'Pancreatitis', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D010195', 'descriptor_name': 'Pancreatitis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010195', 'descriptor_name': 'Pancreatitis', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011799', 'descriptor_name': 'Quinazolines', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D011799', 'descriptor_name': 'Quinazolines', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D011799', 'descriptor_name': 'Quinazolines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013806', 'descriptor_name': 'Theophylline', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D013806', 'descriptor_name': 'Theophylline', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00006676-200211000-00011', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S10058814', 'display_name': 'Pancreas', 'issn_l': '0885-3177', 'issn': ['0885-3177', '1536-4828'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12409834', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.73, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 36, 'referenced_works': ['https://openalex.org/W1546909356', 'https://openalex.org/W1967216992', 'https://openalex.org/W1976615996', 'https://openalex.org/W1981402972', 'https://openalex.org/W1998746287', 'https://openalex.org/W1999688501', 'https://openalex.org/W2004953903', 'https://openalex.org/W2007706349', 'https://openalex.org/W2010492737', 'https://openalex.org/W2019867656', 'https://openalex.org/W2028404746', 'https://openalex.org/W2029551841', 'https://openalex.org/W2030200935', 'https://openalex.org/W2031944053', 'https://openalex.org/W2032354327', 'https://openalex.org/W2035033309', 'https://openalex.org/W2046721360', 'https://openalex.org/W2047811234', 'https://openalex.org/W2050777237', 'https://openalex.org/W2071793636', 'https://openalex.org/W2073977486', 'https://openalex.org/W2076347667', 'https://openalex.org/W2095211207', 'https://openalex.org/W2099757747', 'https://openalex.org/W2107860142', 'https://openalex.org/W2110873261', 'https://openalex.org/W2116927690', 'https://openalex.org/W2131752694', 'https://openalex.org/W2146726943', 'https://openalex.org/W2170227320', 'https://openalex.org/W2173637498', 'https://openalex.org/W2336295169', 'https://openalex.org/W2415325849', 'https://openalex.org/W2467567169', 'https://openalex.org/W4232479519', 'https://openalex.org/W4233805186'], 'related_works': ['https://openalex.org/W3030859185', 'https://openalex.org/W2987313600', 'https://openalex.org/W2430034614', 'https://openalex.org/W2426680130', 'https://openalex.org/W2062660503', 'https://openalex.org/W2020168868', 'https://openalex.org/W1974998794', 'https://openalex.org/W1963861051', 'https://openalex.org/W1382943', 'https://openalex.org/W130088918'], 'abstract_inverted_index': {'Adenosine': [0], 'shows': [1], 'protective': [2], 'effects': [3, 25], 'against': [4], 'cellular': [5], 'damage': [6], 'and': [7, 16, 79, 81, 92, 113, 142, 170], 'dysfunction': [8], 'under': [9], 'several': [10], 'adverse': [11], 'conditions': [12], 'such': [13, 85], 'as': [14, 86], 'inflammation': [15], 'ischemia.': [17], 'In': [18, 137], 'the': [19, 24, 50, 97, 114, 120, 129, 150, 156, 160, 180], 'current': [20], 'study,': [21], 'we': [22], 'examined': [23], 'of': [26, 45, 52, 64, 76, 117, 182], '3-[1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6-dimethyl-2,4(1,3': [27], ')-quinazolinedione': [28], 'hydrochloride': [29], '(KF24345),': [30], 'an': [31, 133], 'adenosine': [32, 46, 134, 145, 161, 175], 'uptake': [33, 47, 146, 162, 176], 'inhibitor,': [34], 'on': [35, 119], 'cerulein-induced': [36, 165], 'acute': [37, 53, 111, 166, 183], 'pancreatitis': [38, 55, 167, 184], 'in': [39, 58, 96, 108, 122, 168, 185], 'mice': [40, 59, 109], 'to': [41], 'investigate': [42], 'whether': [43], 'inhibition': [44, 177], 'could': [48, 178], 'ameliorate': [49, 164, 179], 'severity': [51, 181], 'pancreatitis.Acute': [54], 'was': [56, 126], 'induced': [57], 'with': [60, 110, 131], 'six': [61], 'intraperitoneal': [62], 'injections': [63], 'cerulein': [65, 72], '(50': [66], 'microg/kg': [67], 'each)': [68], 'at': [69], 'hourly': [70], 'intervals.The': [71], 'injection': [73], 'increased': [74], 'activities': [75], 'serum': [77, 123, 152], 'amylase': [78, 124, 153], 'lipase': [80], 'caused': [82], 'pathologic': [83], 'changes': [84, 106], 'interstitial': [87], 'edema,': [88], 'polymorphonuclear': [89], 'cell': [90, 94], 'infiltration,': [91], 'acinar': [93], 'necrosis': [95], 'pancreas.': [98], 'KF24345': [99, 118], '(10': [100], 'mg/kg': [101], 'p.o.)': [102], 'ameliorated': [103], 'all': [104], 'these': [105, 171], 'observed': [107], 'pancreatitis,': [112], 'suppressing': [115], 'effect': [116], 'elevation': [121], 'activity': [125], 'abolished': [127], 'by': [128], 'treatment': [130], '8-(p-sulfophenyl)theophylline,': [132], 'receptor': [135], 'antagonist.': [136], 'addition,': [138], '2-(aminocarbonyl)-': [139], '-(4-amino-2,6-dichlorophenyl)-4-[5,5-bis-(4-fluorophenyl)pentyl]-1-piperazineacetamide': [140], '(R75231)': [141], 'dipyridamole,': [143], 'other': [144], 'inhibitors,': [147], 'also': [148], 'decreased': [149], 'elevated': [151], 'activity.These': [154], 'are': [155], 'first': [157], 'demonstrations': [158], 'that': [159, 174], 'inhibitors': [163], 'mice,': [169], 'data': [172], 'suggest': [173], 'vivo.': [186]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1974761077', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-14T07:32:57.265403', 'created_date': '2016-06-24'}